OpenURL Connection Search

Select item for more details and to access through your institution.

Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials.
Published in:
2016
By:
- Mateos, Maria-Victoria;
- Oriol, Albert;
- Martínez-López, Joaquín;
- Teruel, Ana-Isabel;
- Bengoechea, Enrique;
- Palomera, Luis;
- de Arriba, Felipe;
- Esseltine, Dixie-Lee;
- Cakana, Andrew;
- Pei, Lixia;
- van de Velde, Helgi;
- Miguel, Jesus;
- Martínez-López, Joaquín;
- Miguel, Jesus San
Publication type:
journal article
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation‐Wide cohort study.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6536, doi. 10.1002/cam4.5424
By:
- Ródenas‐Quiñonero, Isabel;
- Chen‐Liang, Tzu;
- Martín‐Santos, Taida;
- Salar, Antonio;
- Fernández‐González, Marta;
- Celades, Carolina;
- Navarro, José‐Tomás;
- Martínez‐Garcia, Ana Belén;
- Andreu, Rafael;
- Balaguer, Aitana;
- Martin García‐Sancho, Alejandro;
- Baile, Mónica;
- López‐Jiménez, Javier;
- Marquet‐Palomanes, Juan;
- Teruel, Ana Isabel;
- Terol, María José;
- Benet, Carmen;
- Frutos, Laura;
- Navarro, José Luis;
- Uña, Jon
Publication type:
Article
P-178: Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S134, doi. 10.1016/S2152-2650(21)02305-3
By:
- Moreno, David;
- Oriol, A.;
- de la Rubia, Javier;
- Hernández, Miguel Teodoro;
- Iñigo, Belen;
- Palomera, Luis;
- de Arriba, Felipe;
- González, Yolanda;
- Teruel, Ana Isabel;
- Granell, Miquel;
- de la Guía, Ana López;
- Mayol, Antonia Sampol;
- Ríos, Rafael;
- Sureda, A.;
- Gutierrez, Norma C.;
- Calasanz, María José;
- Ramos, María Luisa Martin;
- Mateos, María-Victoria;
- San-Miguel, Jesús F.;
- Lahuerta, Juan José
Publication type:
Article
Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e289, doi. 10.1016/j.clml.2019.09.476
By:
- Rubia, Javier De La;
- Pérez, Ariadna;
- Rosinol, Laura;
- Arnao, Mario;
- Teruel, Ana Isabel;
- Herrera, Inmaculada;
- Albo, Carmen;
- Vaz, Carlos;
- Krisnk, Isabel;
- Bermudez, Arancha;
- Pascual, María J.;
- Encinas, Cristina;
- Cabanas, Valentín;
- Jurado, Manuel;
- Gonzalez, Sonia;
- Viguria, Maria C.;
- Chinea, Anabelle;
- Ferra, Christelle;
- Sampol, Antonia;
- Solano, Carlos
Publication type:
Article
The Presence of MDS-like Phenotypic Abnormalities (MDS-PA) Identifies Newly Diagnosed Multiple Myeloma (MM) Patients With MDS/AML-Related Somatic Mutations And Inferior Survival.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e11, doi. 10.1016/j.clml.2017.03.018
By:
- Paiva, Bruno;
- Puig, Noemi;
- Cedena, Maria-Teresa;
- Vazquez, Iria;
- Chillon, Maria-Carmen;
- Ruiz, Yanira;
- Martinez-Lopez, Joaquin;
- Garcia-Sanz, Ramon;
- Gonzalez, Marcos;
- Agirre, Xabier;
- Calasanz, Maria-Jose;
- Burgos, Leire;
- Alignani, Diego;
- Prosper, Felipe;
- Matarraz, Sergio;
- Orfao, Alberto;
- Oriol, Albert;
- Teruel, Ana Isabel;
- Echeveste, María-Asunción;
- de Paz, Raquel
Publication type:
Article
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00647-z
By:
- Mosquera Orgueira, Adrian;
- González Pérez, Marta Sonia;
- Diaz Arias, Jose;
- Rosiñol, Laura;
- Oriol, Albert;
- Teruel, Ana Isabel;
- Martinez Lopez, Joaquin;
- Palomera, Luis;
- Granell, Miguel;
- Blanchard, Maria Jesus;
- de la Rubia, Javier;
- López de la Guia, Ana;
- Rios, Rafael;
- Sureda, Anna;
- Hernandez, Miguel Teodoro;
- Bengoechea, Enrique;
- Calasanz, María José;
- Gutierrez, Norma;
- Martin, Maria Luis;
- Blade, Joan
Publication type:
Article
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
Published in:
PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203392
By:
- Lopez-Anglada, Lucia;
- Cueto-Felgueroso, Cecilia;
- Rosiñol, Laura;
- Oriol, Albert;
- Teruel, Ana Isabel;
- Lopez de la Guia, Ana;
- Bengoechea, Enrique;
- Palomera, Luis;
- de Arriba, Felipe;
- Hernandez, Jose Mariano;
- Granell, Miquel;
- Peñalver, Francisco Javier;
- Garcia-Sanz, Ramon;
- Besalduch, Juan;
- Gonzalez, Yolanda;
- Martinez, Rafael Benigno;
- Hernandez, Miguel Teodoro;
- Gutierrez, Norma C.;
- Puerta, Paloma;
- Valeri, Antonio
Publication type:
Article

Found: 7

Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials.

Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation‐Wide cohort study.

P-178: Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies.

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.

The Presence of MDS-like Phenotypic Abnormalities (MDS-PA) Identifies Newly Diagnosed Multiple Myeloma (MM) Patients With MDS/AML-Related Somatic Mutations And Inferior Survival.

Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group.

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.